FDA Drug Application (203026) for VALSARTAN AND HYDROCHLOROTHIAZIDE by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number203026
Product Number001
FormTABLET;ORAL
Dosage12.5MG;80MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVALSARTAN AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; VALSARTAN

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient VALSARTAN12


Back to FDA Applications sponsored by APOTEX INC